Diabetes I or II Sensor GENESIS
Locations
- Burlingame
Clinical trial FAQs
Information for patients and study volunteers, including frequently asked questions.
The study is a multi-center, prospective single-arm design without controls for adult and pediatric subjects with type 1 or type 2 diabetes. All subjects will be assigned to treatment for 7-17 days of sensor wear. Each subject will wear between 1 and 4 sensors, and each will be connected to/integrated with a transmitter. Subjects 2-12 years of age will wear up to 2 study glucose sensors, subjects 13 years and older will wear up to 4 study glucose sensors.
Email us to enroll
Related clinical trials
View all clinical trials- Clinical trial
Diabetes KOS Argus Continuing Glucose Monitoring System
Argus 2.0 Adoption Study
Status: Coming Soon
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Status: Open to Enrollment
- Clinical trial
Type II Diabetes Mellitus ORA-D-013-3
A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on One to Three Glucose-lowering Agents
Status: Coming Soon
- Clinical trial
Diabetes Type II Pediatric ACHIEVE-PEDS J2A-MC-GZGY
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes
Status: Coming Soon
- Clinical trial
Type 1 Diabetes ONWARDS 11
A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Status: Open to Enrollment